PIANTELLI, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 9.560
EU - Europa 6.313
AS - Asia 5.838
SA - Sud America 719
Continente sconosciuto - Info sul continente non disponibili 563
AF - Africa 99
OC - Oceania 7
Totale 23.099
Nazione #
US - Stati Uniti d'America 9.339
SG - Singapore 2.138
CN - Cina 1.685
UA - Ucraina 1.103
IE - Irlanda 910
TR - Turchia 832
GB - Regno Unito 823
IT - Italia 671
SE - Svezia 662
RU - Federazione Russa 642
BR - Brasile 590
FR - Francia 553
VN - Vietnam 537
DE - Germania 478
IN - India 294
FI - Finlandia 238
CA - Canada 120
BD - Bangladesh 75
HK - Hong Kong 57
MX - Messico 55
PL - Polonia 55
AR - Argentina 42
CZ - Repubblica Ceca 36
ZA - Sudafrica 36
AT - Austria 33
IQ - Iraq 33
BE - Belgio 25
JP - Giappone 23
PK - Pakistan 22
CO - Colombia 20
NL - Olanda 20
ES - Italia 17
UZ - Uzbekistan 17
EC - Ecuador 16
LT - Lituania 16
PH - Filippine 16
VE - Venezuela 15
EU - Europa 14
JM - Giamaica 14
KE - Kenya 14
SA - Arabia Saudita 14
IL - Israele 13
KR - Corea 12
MA - Marocco 12
JO - Giordania 10
EG - Egitto 9
ID - Indonesia 9
UY - Uruguay 9
CL - Cile 8
HN - Honduras 7
IR - Iran 7
PE - Perù 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
GR - Grecia 6
MY - Malesia 6
TN - Tunisia 6
AU - Australia 5
AZ - Azerbaigian 5
BH - Bahrain 5
CR - Costa Rica 5
DZ - Algeria 5
ET - Etiopia 4
MO - Macao, regione amministrativa speciale della Cina 4
RS - Serbia 4
TT - Trinidad e Tobago 4
AO - Angola 3
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
CH - Svizzera 3
GT - Guatemala 3
NI - Nicaragua 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GD - Grenada 2
HU - Ungheria 2
KZ - Kazakistan 2
LB - Libano 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RO - Romania 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
CI - Costa d'Avorio 1
CU - Cuba 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HT - Haiti 1
KG - Kirghizistan 1
Totale 22.541
Città #
Singapore 1.471
Jacksonville 1.172
San Jose 1.092
Chandler 1.089
Dublin 906
Southend 637
Ashburn 542
Council Bluffs 457
Izmir 433
Princeton 423
Dallas 388
Beijing 339
Nanjing 329
Wilmington 237
Los Angeles 224
Dearborn 217
Santa Clara 216
Cambridge 202
Ho Chi Minh City 185
Tongling 152
Ann Arbor 143
Boardman 135
New York 122
Hanoi 120
Nanchang 112
Buffalo 109
Chieti 109
The Dalles 104
Moscow 94
Woodbridge 91
Altamura 79
Shenyang 73
Munich 70
São Paulo 70
Grevenbroich 59
Hebei 59
Tianjin 56
Jiaxing 53
Houston 51
Redondo Beach 51
Hong Kong 46
Orem 44
London 36
Columbus 35
Hefei 35
Norwalk 35
Phoenix 35
Denver 33
Changsha 32
Jinan 31
Johannesburg 31
Pescara 31
Rome 31
Toronto 31
Brno 29
Chennai 29
Chicago 29
Collecorvino 29
Grafing 29
Montreal 29
Warsaw 29
Brooklyn 28
Kunming 28
Milan 28
Vienna 27
Washington 26
Atlanta 25
Dong Ket 24
Mexico City 24
Turku 24
Brussels 23
Da Nang 23
Helsinki 23
Manchester 22
Tokyo 22
Augusta 21
Boston 21
Kraków 21
Orange 21
Haiphong 20
Hangzhou 20
Rio de Janeiro 19
San Mateo 18
Guangzhou 17
Mumbai 17
Seattle 17
Poplar 16
Tashkent 15
Ningbo 14
Stockholm 14
Frankfurt am Main 13
Lanzhou 13
Ottawa 13
San Vito Chietino 13
Amsterdam 12
Andover 12
Baghdad 12
Nairobi 12
Salvador 12
Seoul 12
Totale 13.902
Nome #
A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer 260
Tamoxifene e quercetina inibiscono la proliferazione di cellule neoplastiche polmonari "non small cell" in coltura e nei tumori primitivi. 254
Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology 248
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 224
A unique four-hub protein cluster associates to glioblastoma progression 221
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma 211
Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice 196
Trop-2 is a determinant of breast cancer survival. 192
90K (Mac-2 BP) and galectins in tumor progression and metastasis. 189
The flavonoid quercetin regulates growth and gene expression in rat FRTL-5 thyroid cells 178
Trop-2 activates a dormant Na/K-ATPase/PKCa/CD9/ezrin signaling axis to override the basal growth program of cancer cells 175
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer. 173
Apoptosi spontanea ed indotta da glicocorticoidi nei linfociti T periferici umani 170
CD133, Trop-2 and alpha2beta1 integrin surface receptors as markers of putative human prostate cancer stem cells 169
Upregulation of Trop-2 quantitatively stimulates human cancer growth 168
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 163
Interleukin 1alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells. 162
P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations 160
The Trop-2 signalling network in cancer growth 160
Prognostic relevance of LGALS3BP in human colorectal carcinoma 160
Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. 159
A solid phase radioimmunoassay for the diagnosis of human hydatidosis. 159
Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations 158
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer 157
Trop-1 are conserved growth stimulatory molecules that mark early stages of tumor progression 156
Antioxidant strategies based on tomato-enriched food or pyruvate do not affect disease onset and survival of amyotrophic lateral sclerosis 155
Analisi dello stato mutazionale di K-RAS: un nuovo strumento per la selezione dei pazienti candidati a terapia con anticorpi anti-EGFR 154
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 154
Molecular studies of pulmonary carcinoids 153
A Dietary Tomato Supplement Prevents Prostate Cancer in TRAMP Mice 151
[Proteomics analysis of solid tumors] 151
Resveratrol inhibits sodium/iodide symporter gene expression and function in rat thyroid cells 149
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 149
The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer. 148
Overexpression of PY1289-HER3 in sporadic pulmonary carcinoid from patients bearing MEN1 gene variants 148
Trop-2 induces tumor growth through Akt and determines sensitivity to Akt inhibitors 147
Features of endothelial dysfunction in umbilical cord vessels of women with gestational diabetes 147
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression 147
Depletion of stromal and intraepithelial antigen-presenting cells in vervical neoplasia in human immunodificiency virus infection 145
Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction 144
The Flavonoid Quercetin inhibits thyroid function in rats 144
Growth inhibitory mechanism of quercetin and tamoxifen in human lung cancer cell lines 143
Alterations of MEN1 and E-cadherin/β-catenin complex in sporadic pulmonary carcinoids 142
Flavonoids Apigenin and Quercetin inhibit melanoma growth and metastatic potential 141
Quercetin increases Major Histocompatibility Complex (MHC) class I expression in thyroid cells 139
T3 expression by human thymocytes in culture. 138
[Tissue microarrays] 138
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. 137
Methylation analysis of protocadherin genes in pancreatic adenocarcinoma 136
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 136
Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion 135
Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells. 134
The mature, mitogen-responsive, human thymocyte population comprises two functionally distinct T-cell subsets differing in exogenous interleukin requirements for mitogenesis and in sensitivity to glucocorticoids. 134
Quercetin and tamoxifen sensitize human melanoma cells to hyprthermia. 133
Estrogen binding sites in peripheral blood mononuclear cells and thymocytes from 2 myastenia gravis patients. 133
Alterations in thymocyte subpopulations in Down's syndrome (trisomy 21). 133
INTERACTION WITH TYPE II ESTROGEN BINDING SITES AND ANTIPROLIFERATIVE ACTIVITY OF TAMOXIFEN AND QUERCETIN IN HUMAN NON SMALL CELL LUNG CANCER. 132
Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival 132
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody. 132
Vav1 down-modulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome 132
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading 131
mTrop1/Epcam Knockout Mice Develop Congenital Tufting Enteropathy through Dysregulation of Intestinal E-cadherin/β-catenin 130
The flavonoid quercetin inhibits thyroid-restricted genes expression and thyroid function. 130
Growth inhibitory effect of quercetin and tamoxifen and presence of type II estrogen-binding sites in human lung cancer cell lines and primary tumors 128
Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin. 128
Sunitinib malate (SU-11248) alone or in combination with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts. 128
IL-10 synergizes with dexamethasone in inhibiting human T cell proliferation. 127
Effect of synthetic and naturally occurring chalcones on ovarian cancer cell growth: structure-activity relationships. 125
Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions. 124
Inhibition of thyroid function by polyphenols 124
Axillary Lymph Node Nanometastases are Prognostic Factors for Disease-Free Survival and Metastatic Relapse in Breast Cancer Patients 123
Alpha-l-antitrypsin deficiency and human pathology. 123
Proinflammatory cytokines IL1 and IL6 are autocrine and/or paracrine growth factors for normal and neoplastic epithelial cells from human uterine cervix. 123
The splicing factor PTBP1 promotes expression of oncogenic splice variants and predicts poor prognosis in patients with non-muscle-invasive bladder cancer 123
Morphometric Prognostic Index in Breast Cancer 122
Alloantisera defining surface antigens on human thymocytes. 122
Alpha-1-antitrypsin phenotypes in newborns from Central and Southern Italy. 121
Ultrastructural analysis of peripheral blood mononuclear cells in renal allograft recipients. 120
Comment on "cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice" 120
Differential sensitivity of leukemic and normal hematopoietic progenitors to the killing effect of hyperthermia and quercetin used in combination: role of heat-shock protein- 70. 117
Proliferation of phenotypically immature human thymocytes with and without interleukin 2 receptors. 116
Inhibitory effect of cyclosporin A on the OKT3-induced peripheral blood lymphocyte proliferation. 116
Role of phospholipase C in cell invasion and metastasis 116
An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling. 116
Interaction of tamoxifen with cytosolic and nuclear type II estrogen binding sites (type II EBS) 115
Expression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in ameloblastoma. 115
The flavonoid quercetin inhibits thyroid function in rats 115
Quercetin inhibits the growth of leukemic progenitors and induces the expression of transforming growth factor-beta1 in these cells 114
Glucocorticoid inhibitory action on OKT3 stimulated peripheral blood lymphocytes from renal transplant patients. 114
Proliferative capabilities of T3-positive thymocytes. 114
A human thymoma with prothymocyte-like infiltration. 114
Alpha-1-antitrypsin in umbilical cord serum: pi phenotypes and relationships with idiopathic respiratory distress syndrome. 114
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine 114
Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals 113
Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer 113
Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma. 111
Intestinal tumour chemoprevention with the antioxidant lipoic acid stimulates the growth of breast cancer. 111
Phospholipase Cgamma1 is required for metastasis development and progression 111
IL-10 Synergizes with Dexamethasone in Inhibiting Human T Cell Proliferation 110
Antiproliferative activity of quercetin on normal bone marrow and leukaemic progenitors. 110
Totale 14.349
Categoria #
all - tutte 90.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.028


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022885 0 0 16 172 100 39 20 76 56 27 123 256
2022/20232.963 252 328 146 352 330 605 174 254 343 33 87 59
2023/20241.262 94 45 79 32 84 368 332 44 16 18 9 141
2024/20253.062 146 523 419 99 63 93 77 232 382 113 311 604
2025/20266.374 546 245 695 800 490 426 1.011 477 609 544 424 107
2026/2027602 95 397 110 0 0 0 0 0 0 0 0 0
Totale 23.099